Eli Lilly is taking steps to help diabetics afford insulin during the pandemic after patient advocates asked the three big insulin makers to lower prices. However, the company is offering additional copay assistance, not lowering prices. “Patients made this happen. We're happy to see modest progress from Eli Lilly, but we still need action to lower list prices for all Americans -- from Lilly, Sanofi, and Novo Nordisk,” Patients for Affordable Drugs Deputy Executive Director Lucy Westerfield said. “We are...